Osteoporosis Therapeutics in Asia-Pacific, Industry, Pharmaceutical - for future Market Growth, Challenges, Industrial Demand, Forecast 2016-2025
"Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies" . The Report covers current Market Trends, Analysis, Forecast, Review, Share, Size, Growth, Effect. Description- Osteoporosis , the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a consequent increase in fracture risk. Osteoporosis is generally known as an asymptomatic disease, as there are no visible signs until a fracture occur. In most of the cases, fracture is the clinical outcome associated with osteoporosis, and it has a complex pathogenesis that involves trauma to the bone and increased skeletal fragility. Osteoporosis is a major global public health problem, associated with significant morbidity, mortality, and socioeconomic burden. An aging global population will result in an increased number of people living with the conditi